Login / Signup

Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.

Yajie WangYiran LiangFangzhou YeDan LuoYuhan JinYaming LiWenjing ZhaoBing ChenLijuan WangQifeng Yang
Published in: Cancer medicine (2023)
Histological subtypes are involved in determining the heterogeneity of HER2+ MBC patient prognosis, which is helpful to guide the prognosis prediction and monitoring of HER2+ breast cancer patients in clinics.
Keyphrases
  • metastatic breast cancer
  • case report
  • single cell
  • primary care
  • emergency department
  • adverse drug